Quoin Pharmaceuticals Ltd - ADR (QNRX) stock is unchanged 0.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator. Quoin Pharmaceuticals Ltd - ADR has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on QNRX! See Full QNRX Report What is Stock Sentiment? In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall. What's Happening With QNRX Stock Today? Quoin Pharmaceuticals Ltd - ADR (QNRX) stock is trading at $2.14 as of 11:06 AM on Monday, Dec 27, a gain of $0.16, or 8.08% from the previous closing price of $1.98. The stock has traded between $1.86 and $2.17 so far today. Volume today is light. So far 872,167 shares have traded compared to average volume of 1,898,418 shares. More About Quoin Pharmaceuticals Ltd - ADR Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. Click Here to get the full Stock Report for Quoin Pharmaceuticals Ltd - ADR stock.
Stock Price data may be delayed up to 15 minutes.
Copyright © 2021. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy